Common Stock, Shares, Issued of KalVista Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
KalVista Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 50,542,711, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,542,711 +7,271,210 +17% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 50,339,823 +7,257,901 +17% 31 Jul 2025 10-Q 11 Sep 2025 2026 Q1
Q1 2025 49,762,048 +7,240,073 +17% 30 Apr 2025 10-Q 11 Sep 2025 2026 Q1
Q4 2024 49,433,611 +14,837,988 +43% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 43,271,501 +8,850,043 +26% 31 Oct 2024 10-Q 05 Dec 2024 2025 Q2
Q2 2024 43,081,922 +8,815,327 +26% 31 Jul 2024 10-Q 05 Sep 2024 2025 Q1
Q1 2024 42,521,975 +8,350,837 +24% 30 Apr 2024 10-K 10 Jul 2025 2025 FY
Q4 2023 34,595,623 +467,861 +1.4% 31 Jan 2024 10-Q 11 Mar 2024 2024 Q3
Q3 2023 34,421,458 +9,819,435 +40% 31 Oct 2023 10-Q 07 Dec 2023 2024 Q2
Q2 2023 34,266,595 +9,695,723 +39% 31 Jul 2023 10-Q 07 Sep 2023 2024 Q1
Q1 2023 34,171,138 +9,620,390 +39% 30 Apr 2023 10-K 11 Jul 2024 2024 FY
Q4 2022 34,127,762 +9,590,668 +39% 31 Jan 2023 10-Q 09 Mar 2023 2023 Q3
Q3 2022 24,602,023 +158,591 +0.65% 31 Oct 2022 10-Q 08 Dec 2022 2023 Q2
Q2 2022 24,570,872 +133,357 +0.55% 31 Jul 2022 10-Q 08 Sep 2022 2023 Q1
Q1 2022 24,550,748 +128,217 +0.52% 30 Apr 2022 10-K 10 Jul 2023 2023 FY
Q4 2021 24,537,094 +6,515,870 +36% 31 Jan 2022 10-Q 10 Mar 2022 2022 Q3
Q3 2021 24,443,432 +6,527,917 +36% 31 Oct 2021 10-Q 09 Dec 2021 2022 Q2
Q2 2021 24,437,515 +6,557,101 +37% 31 Jul 2021 10-Q 09 Sep 2021 2022 Q1
Q1 2021 24,422,531 +6,576,932 +37% 30 Apr 2021 10-K 07 Jul 2022 2022 FY
Q4 2020 18,021,224 +175,625 +0.98% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q3
Q3 2020 17,915,515 +81,389 +0.46% 31 Oct 2020 10-Q 10 Dec 2020 2021 Q2
Q2 2020 17,880,414 +64,921 +0.36% 31 Jul 2020 10-Q 14 Sep 2020 2021 Q1
Q1 2020 17,845,599 +567,849 +3.3% 30 Apr 2020 10-K 13 Jul 2021 2021 FY
Q4 2019 17,845,599 +598,293 +3.5% 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 17,834,126 +608,959 +3.5% 31 Oct 2019 10-Q 03 Dec 2019 2020 Q2
Q2 2019 17,815,493 +7,015,598 +65% 31 Jul 2019 10-Q 09 Sep 2019 2020 Q1
Q1 2019 17,277,750 +6,477,855 +60% 30 Apr 2019 10-K 01 Jul 2020 2020 FY
Q4 2018 17,247,306 +6,454,660 +60% 31 Jan 2019 10-Q 14 Mar 2019 2019 Q3
Q3 2018 17,225,167 +6,441,536 +60% 31 Oct 2018 10-Q 14 Dec 2018 2019 Q2
Q2 2018 10,799,895 +1,086,853 +11% 31 Jul 2018 10-Q 14 Sep 2018 2019 Q1
Q1 2018 10,799,895 +1,086,853 +11% 30 Apr 2018 10-K 16 Jul 2019 2019 FY
Q4 2017 10,792,646 +1,079,604 +11% 31 Jan 2018 10-Q 16 Mar 2018 2018 Q3
Q3 2017 10,783,631 -15,560,473 -59% 31 Oct 2017 10-Q 14 Dec 2017 2018 Q2
Q2 2017 9,713,042 -16,622,733 -63% 31 Jul 2017 10-Q 14 Sep 2017 2018 Q1
Q1 2017 9,713,042 -16,619,452 -63% 30 Apr 2017 10-K 30 Jul 2018 2018 FY
Q4 2016 9,713,042 -16,609,452 -63% 31 Jan 2017 10-Q 16 Mar 2017 2016 Q3
Q3 2016 26,344,104 +21,610 +0.08% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 26,335,775 +13,281 +0.05% 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 26,332,494 +25,624,037 +3617% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 26,322,494 +25,631,182 +3708% 31 Dec 2015 10-Q 08 Nov 2016 2016 Q3
Q3 2015 26,322,494 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 26,322,494 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 708,457 31 Mar 2015 10-Q 21 May 2015 2015 Q1
Q4 2014 691,312 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.